Cue Biopharma, Inc.
CUE
$30.50
$0.501.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.41M | 17.44M | 28.23M | 20.42M | 27.96M |
| Total Receivables | 5.38M | 7.25M | 7.45M | 2.29M | 532.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.93M | 1.70M | 1.31M | 3.11M | 2.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.90M | -- | -- | -- | -- |
| Total Current Assets | 26.62M | 26.39M | 36.98M | 25.82M | 30.84M |
|
|
|||||
| Total Current Assets | 26.62M | 26.39M | 36.98M | 25.82M | 30.84M |
| Net Property, Plant & Equipment | 3.21M | 3.61M | 4.32M | 4.91M | 5.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 870.00K | 879.00K | 914.00K | 916.00K | 4.29M |
| Total Assets | 30.71M | 30.88M | 42.21M | 31.64M | 40.71M |
|
|
|||||
| Total Accounts Payable | 3.75M | 3.33M | 3.95M | 2.35M | 3.63M |
| Total Accrued Expenses | 14.88M | 1.50M | 1.61M | 1.87M | 1.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.63M | 1.56M | 1.91M | 3.49M | 4.53M |
| Total Finance Division Other Current Liabilities | 960.00K | 1.00M | 6.02M | 7.82M | 9.58M |
| Total Other Current Liabilities | 960.00K | 1.00M | 6.02M | 7.82M | 9.58M |
| Total Current Liabilities | 21.22M | 7.39M | 13.49M | 15.52M | 19.25M |
|
|
|||||
| Total Current Liabilities | 21.22M | 7.39M | 13.49M | 15.52M | 19.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.45M | 1.88M | 2.29M | 2.68M | 3.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.73M | -- | -- | 190.00K | 190.00K |
| Total Liabilities | 28.40M | 9.27M | 15.78M | 18.40M | 22.55M |
|
|
|||||
| Common Stock & APIC | 529.02M | 395.25M | 394.90M | 383.30M | 380.76M |
| Retained Earnings | -526.71M | -373.64M | -368.47M | -370.05M | -362.60M |
| Treasury Stock & Other | -- | -- | -- | 1.00K | -- |
| Total Common Equity | 2.31M | 21.61M | 26.43M | 13.25M | 18.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.31M | 21.61M | 26.43M | 13.25M | 18.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.31M | 21.61M | 26.43M | 13.25M | 18.16M |
|
|
|||||